Satoko Nakada Selected Research

Satoko Nakada Research Topics

Disease

13	Neoplasms (Cancer) 07/2023 - 09/2006
4	Glioma (Gliomas) 03/2010 - 09/2006
2	Meningioma (Meningiomas) 01/2022 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2018
2	Renal Insufficiency (Renal Failure) 03/2019 - 01/2018
2	Thrombocytopenia (Thrombopenia) 03/2019 - 01/2018
2	Edema (Dropsy) 03/2019 - 01/2018
2	Fever (Fevers) 03/2019 - 01/2018
2	Fibrosis (Cirrhosis) 03/2019 - 01/2018
2	Castleman Disease (Castleman's Disease) 03/2019 - 01/2018
2	Multi-centric Castleman's Disease 03/2019 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 03/2010 - 09/2006
2	Brain Neoplasms (Brain Tumor) 03/2010 - 04/2007
1	Aneurysm (Aneurysms) 01/2024
1	Hepatocellular Carcinoma (Hepatoma) 02/2023
1	Polycystic liver disease 08/2021
1	Congenital Hepatic Fibrosis 08/2021
1	Caroli Disease (Caroli's Disease) 08/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Lymphatic Metastasis 01/2020
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 03/2019
1	Adenosquamous Carcinoma 01/2019
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2019
1	Necrosis 01/2018
1	Hypogonadism (Hypergonadotropic Hypogonadism) 09/2016
1	Erectile Dysfunction 09/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2016
1	Residual Neoplasm 09/2016
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 09/2016
1	Mediastinal Cyst 07/2015
1	Adenocarcinoma 01/2013
1	Adenocarcinoma in Situ 01/2013
1	Astrocytoma (Pilocytic Astrocytoma) 03/2010
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 07/2008
1	Carcinogenesis 04/2007

Drug/Important Bio-Agent (IBA)

2	Hormones (Hormone)IBA 01/2022 - 09/2016
2	Interleukin-6 (Interleukin 6)IBA 03/2019 - 01/2018
2	Reticulin (Reticular Fiber)IBA 03/2019 - 01/2018
2	LigandsIBA 03/2010 - 09/2006
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 07/2023
1	Glutamate Receptors (Glutamate Receptor)IBA 05/2023
1	gadolinium ethoxybenzyl DTPA FDA Link 02/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	1-dodecylpyridoxal (PLD)IBA 08/2021
1	Imatinib Mesylate (Gleevec)FDA Link 01/2021
1	MucinsIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019
1	LipidsIBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	AntioxidantsIBA 01/2018
1	PeroxiredoxinsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2018
1	ChromatinIBA 01/2018
1	EnzymesIBA 01/2018
1	GonadotropinsIBA 09/2016
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 09/2016
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 09/2016
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 09/2016
1	Testosterone (Sustanon)FDA Link 09/2016
1	Colloids (Colloid)IBA 07/2015
1	ParaffinIBA 01/2013
1	Glial Fibrillary Acidic ProteinIBA 02/2011
1	AcidsIBA 02/2011
1	Ephrin-B1 (Ephrin B1)IBA 03/2010
1	Ephrin-B2 (Ephrin B2)IBA 03/2010
1	beta-Galactosidase (Lactaid)IBA 07/2008
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2008
1	Small Interfering RNA (siRNA)IBA 01/2008
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2007
1	Mitogen-Activated Protein KinasesIBA 04/2007
1	MAP Kinase Kinase 3IBA 04/2007
1	Temozolomide (Temodar)FDA LinkGeneric 04/2007
1	Biomarkers (Surrogate Marker)IBA 04/2007
1	p38 Mitogen-Activated Protein KinasesIBA 04/2007
1	Ephrin-B3 (Ephrin B3)IBA 09/2006
1	EphrinsIBA 09/2006
1	Messenger RNA (mRNA)IBA 09/2006

Therapy/Procedure

6	Therapeutics 05/2023 - 04/2007
3	Radiotherapy 01/2022 - 09/2016
3	Lasers (Laser) 03/2010 - 09/2006
1	Cerebral Revascularization 01/2024
1	Colectomy 01/2021
1	Gastrectomy 01/2021
1	Adjuvant Chemotherapy 01/2020
1	Hysterectomy 01/2019
1	Craniotomy 09/2016
1	Drug Therapy (Chemotherapy) 04/2007